imidazopyridiner
Filtrerade sökresultat
CXCR7 modulator 2, MedChemExpress
MedChemExpress CXCR7 modulator 2 is a modulator of C-X-C Chemokine Receptor Type 7 (CXCR7), with a Ki of 13 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C29H42N6O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 522.68 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 250 mg/mL (478.30 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Yellow |
| CAS | 2227426-37-9 |
| LEDER | O=C([C@@H]1[C@H](O2)CC[C@H]2C1)N3CCC([C@H](CC(N)=O)N4CCCN(C5=C(CC)C=CN6C5=NC=C6)CC4)CC3 |
| Molekylvikt (g/mol) | 522.68 |
| Kemiskt namn eller material | CXCR7 modulator 2 |
| Procent renhet | 98.39% |
| För användning med (applikation) | Neuroscience-Neuromodulation |
Dipraglurant, MedChemExpress
MedChemExpress Dipraglurant (ADX48621) is a potent, selective, orally active and brain penetrant mGluR5 negative allosteric modulator (NAM), with an IC50 of 21 nM. Dipraglurant can reduce Levodopa-induced dyskinesia (LID) in vivo.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C16H12FN3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 265.29 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 40 mg/mL (150.78 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 872363-17-2 |
| LEDER | FC1=CN2C(C=C1)=NC(CCC#CC3=NC=CC=C3)=C2 |
| Molekylvikt (g/mol) | 265.29 |
| Synonym | ADX48621 |
| Kemiskt namn eller material | Dipraglurant |
| Procent renhet | 95.95% |
| För användning med (applikation) | Neuroscience-Neurodegeneration |
Linaprazan, MedChemExpress
MedChemExpress Linaprazan (AZD0865) inhibits gastric H+,K+-ATPase by K+-competitive binding.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C21H26N4O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 366.46 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 35 mg/mL (95.51 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 248919-64-4 |
| LEDER | O=C(C1=CN2C(C(NCC3=C(C)C=CC=C3C)=C1)=NC(C)=C2C)NCCO |
| Molekylvikt (g/mol) | 366.46 |
| Synonym | AZD0865 |
| Kemiskt namn eller material | Linaprazan |
| Procent renhet | 98.8% |
| För användning med (applikation) | Cancer-programmed cell death |
IRAK inhibitor 1, MedChemExpress
MedChemExpress IRAK inhibitor 1 is a potent IRAK-4 inhibitor with IC50 of 216 nM, is poorly active against JNK-1 and JNK-2 with IC50 of 3.801 μM, and >10 μM, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C17H19N5 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 293.37 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 16.67 mg/mL (56.82 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Yellow |
| CAS | 1042224-63-4 |
| LEDER | C1(C2=CN=C3N2C=CC=C3)=CC=CC(NC4CCNCC4)=N1 |
| Molekylvikt (g/mol) | 293.37 |
| Kemiskt namn eller material | IRAK inhibitor 1 |
| Procent renhet | 98.05% |
| För användning med (applikation) | COVID-19-immunoregulation |
Pumaprazole, MedChemExpress
MedChemExpress Pumaprazole is a reversible proton pump antagonist.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C19H22N4O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 338.4 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 100 mg/mL (295.51 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Yellow |
| CAS | 158364-59-1 |
| LEDER | O=C(OC)NC1=CC=CC(C)=C1CNC2=CC=CN3C2=NC(C)=C3C |
| Molekylvikt (g/mol) | 338.4 |
| Synonym | BY-841 |
| Kemiskt namn eller material | Pumaprazole |
| Procent renhet | 99.9% |
| För användning med (applikation) | COVID-19-immunoregulation |
Savolitinib, MedChemExpress
MedChemExpress Savolitinib (AZD-6094) is a potent, highly selective, and orally bioavailable c-Met inhibitor with IC50 s of 5 nM and 3 nM for c-Met and p-Met, respectively. Savolitinib (AZD-6094) selectively binds to and inhibits the activation of c-Met in an ATP-competitive manner, and disrupts c-Met signal transduction pathways. Antineoplastic activity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C17H15N9 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 345.36 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 25 mg/mL (72.39 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 1313725-88-0 |
| LEDER | CN1N=CC(C2=CN=C3C(N([C@H](C4=CN5C(C=C4)=NC=C5)C)N=N3)=N2)=C1 |
| Molekylvikt (g/mol) | 345.36 |
| Synonym | Volitinib HMPL-504 AZD-6094 |
| Kemiskt namn eller material | Savolitinib |
| Procent renhet | 98.45% |
| För användning med (applikation) | Cancer-Kinase/protease |
PDE10-IN-1, MedChemExpress
MedChemExpress PDE10-IN-1 is a potent PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1, for treating CNS and metabolic disorders.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C21H19N7 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 369.42 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 2 mg/mL (5.41 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Earth Yellow |
| CAS | 1516896-09-5 |
| LEDER | CC1=C([C@H]2[C@H](C3=NN4C(C(C)=NC=C4C)=N3)C2)N=C5C6=C(N=CC=C6)C=CN51 |
| Molekylvikt (g/mol) | 369.42 |
| Kemiskt namn eller material | PDE10-IN-1 |
| Procent renhet | 97.82% |
| För användning med (applikation) | Neuroscience-Neuromodulation |
Serabelisib, MedChemExpress
MedChemExpress Serabelisib (MLN1117) is a selective p110α inhibitor with an IC50 of 15 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C19H17N5O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 363.37 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 6.4 mg/mL (17.61 mM; Need ultrasonic and warming) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Gray |
| CAS | 1268454-23-4 |
| LEDER | O=C(C1=CN=C2C=CC(C3=CC=C(OC(N)=N4)C4=C3)=CN21)N5CCOCC5 |
| Molekylvikt (g/mol) | 363.37 |
| Synonym | MLN1117 INK1117 TAK-117 |
| Kemiskt namn eller material | Serabelisib |
| Procent renhet | 98.1% |
| För användning med (applikation) | Cancer-Kinase/protease |
JK184, MedChemExpress
MedChemExpress JK184 is a potent Hedgehog (Hh) pathway inhibitor with IC50 of 30 nM in mammalian cells.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C19H18N4OS |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 350.44 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H302∣H315∣H319∣H335 |
| Löslighetsinformation | DMSO : ≥ 50 mg/mL (142.68 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Pink |
| CAS | 315703-52-7 |
| LEDER | CC1=C(C2=CSC(NC3=CC=C(OCC)C=C3)=N2)N4C=CC=CC4=N1 |
| Molekylvikt (g/mol) | 350.44 |
| Kemiskt namn eller material | JK184 |
| Procent renhet | 99.37% |
| För användning med (applikation) | Cancer-programmed cell death |
Antitumor agent-3, MedChemExpress
MedChemExpress Antitumor agent-3 is a potent compound which comprises a new imidazopyridine having excellent antitumor activity as an active ingredient.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C18H10F6N4S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 428.35 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 59 mg/mL (137.74 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 420126-30-3 |
| LEDER | FC(C1=CC=C(NC2=NC(C3=C(C(F)(F)F)N=C4C=CC=CN43)=CS2)C=C1)(F)F |
| Molekylvikt (g/mol) | 428.35 |
| Kemiskt namn eller material | Antitumor agent-3 |
| Procent renhet | 99.71% |
| För användning med (applikation) | Cancer-programmed cell death |
Soraprazan, MedChemExpress
MedChemExpress Soraprazan (BYK61359) is a selective, reversible K-competitive inhibitor of the H,K-ATPase (Ki=6.4 nM), with an IC50 of 0.19 μM in gastric glands. Soraprazan binds to the H,K-ATPase with a Kd of 28.27 nM. Soraprazan shows immediate inhibition of acid secretion and is more than 2000-fold selective for H,K-ATPase over Na,K- and Ca-ATPases.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C21H25N3O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 367.44 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 150 mg/mL (408.23 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Yellow |
| CAS | 261944-46-1 |
| LEDER | O[C@@H]1[C@@H](C2=CC=CC=C2)NC3=C(C=CN4C3=NC(C)=C4C)[C@H]1OCCOC |
| Molekylvikt (g/mol) | 367.44 |
| Synonym | BYK61359 |
| Kemiskt namn eller material | Soraprazan |
| Procent renhet | 99.69% |
Olprinone Hydrochloride, MedChemExpress
MedChemExpress Olprinone (Loprinone) Hydrochloride is a potent phosphodiesterase (PDE) 3 inhibitor, with IC50s of 150, 100, 0.35 and 14 μM for PDE1, PDE2, PDE3 and PDE4, respectively. Olprinone Hydrochloride is used for the research of heart failure due to its positive inotropic and vasodilative effects. Anti-inflammatory activity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C14H11ClN4O |
|---|---|
| Rekommenderad förvaring | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Formel vikt | 286.72 |
| Hållbarhet | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Hälsofara 1 | H315∣H319∣H335 |
| Löslighetsinformation | H2O : ≥ 7.69 mg/mL (26.82 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 119615-63-3 |
| LEDER | CC(N1)=C(C=C(C#N)C1=O)C2=CN3C(C=C2)=NC=C3.[H]Cl |
| Molekylvikt (g/mol) | 286.72 |
| Synonym | Loprinone Hydrochloride |
| Kemiskt namn eller material | Olprinone Hydrochloride |
| Procent renhet | 99.91% |
| För användning med (applikation) | COVID-19-immunoregulation |
DGAT1-IN-1, MedChemExpress
MedChemExpress DGAT1-IN-1 is a potent DGAT1 inhibitor with IC50 of < 10 nM(cell lysate from Hep3B cells overexpressing human DGAT1).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C30H28F3N3O4 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 551.56 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 20 mg/mL (36.26 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 1449779-49-0 |
| LEDER | OC(C[C@H]1CC[C@H](C2=CC=C(C3=CN4C=C(C(NCC5=CC=C(OC(F)(F)F)C=C5)=O)N=C4C=C3)C=C2)CC1)=O |
| Molekylvikt (g/mol) | 551.56 |
| Kemiskt namn eller material | DGAT1-IN-1 |
| Procent renhet | 95.0% |
| För användning med (applikation) | Metabolism-sugar/lipid metabolism |